Article

Transcriptional responses to fatty acid are coordinated by combinatorial control

Institute for Systems Biology, Seattle, WA 98103-8904, USA.
Molecular Systems Biology (Impact Factor: 14.1). 02/2007; 3:115. DOI: 10.1038/msb4100157
Source: PubMed

ABSTRACT In transcriptional regulatory networks, the coincident binding of a combination of factors to regulate a gene implies the existence of complex mechanisms to control both the gene expression profile and specificity of the response. Unraveling this complexity is a major challenge to biologists. Here, a novel network topology-based clustering approach was applied to condition-specific genome-wide chromatin localization and expression data to characterize a dynamic transcriptional regulatory network responsive to the fatty acid oleate. A network of four (predicted) regulators of the response (Oaf1p, Pip2p, Adr1p and Oaf3p) was investigated. By analyzing trends in the network structure, we found that two groups of multi-input motifs form in response to oleate, each controlling distinct functional classes of genes. This functionality is contributed in part by Oaf1p, which is a component of both types of multi-input motifs and has two different regulatory activities depending on its binding context. The dynamic cooperation between Oaf1p and Pip2p appears to temporally synchronize the two different responses. Together, these data suggest a network mechanism involving dynamic combinatorial control for coordinating transcriptional responses.

1 Follower
 · 
110 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Multidrug/Multixenobiotic resistance (MDR/MXR) is a widespread phenomenon with clinical, agricultural and biotechnological implications, where MDR/MXR transporters that are presumably able to catalyze the efflux of multiple cytotoxic compounds play a key role in the acquisition of resistance. However, although these proteins have been traditionally considered drug exporters, the physiological function of MDR/MXR transporters and the exact mechanism of their involvement in resistance to cytotoxic compounds are still open to debate. In fact, the wide range of structurally and functionally unrelated substrates that these transporters are presumably able to export has puzzled researchers for years. The discussion has now shifted toward the possibility of at least some MDR/MXR transporters exerting their effect as the result of a natural physiological role in the cell, rather than through the direct export of cytotoxic compounds, while the hypothesis that MDR/MXR transporters may have evolved in nature for other purposes than conferring chemoprotection has been gaining momentum in recent years. This review focuses on the drug transporters of the Major Facilitator Superfamily (MFS; drug:H(+) antiporters) in the model yeast Saccharomyces cerevisiae. New insights into the natural roles of these transporters are described and discussed, focusing on the knowledge obtained or suggested by post-genomic research. The new information reviewed here provides clues into the unexpectedly complex roles of these transporters, including a proposed indirect regulation of the stress response machinery and control of membrane potential and/or internal pH, with a special emphasis on a genome-wide view of the regulation and evolution of MDR/MXR-MFS transporters.
    Frontiers in Physiology 05/2014; 5:180. DOI:10.3389/fphys.2014.00180
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Systems cell biology melds high-throughput experimentation with quantitative analysis and modeling to understand many critical processes that contribute to cellular organization and dynamics. Recently, there have been several advances in technology and in the application of modeling approaches that enable the exploration of the dynamic properties of cells. Merging technology and computation offers an opportunity to objectively address unsolved cellular mechanisms, and has revealed emergent properties and helped to gain a more comprehensive and fundamental understanding of cell biology.
    The Journal of Cell Biology 09/2014; 206(6):695-706. DOI:10.1083/jcb.201405027 · 9.69 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The toxic subcellular accumulation of lipids predisposes several human metabolic syndromes including obesity, type 2 diabetes and some forms of neurodegeneration. To identify pathways that prevent lipid-induced cell death, we performed a genome-wide, fatty acid sensitivity screen in Saccharomyces cerevisiae. We identified 160 yeast mutants as sensitive to 0.5 mM palmitoleate, 45% of which define pathways that were conserved in humans. 63 lesions also impacted the status of the lipid droplet, however this was not correlated to the degree of fatty acid sensitivity. The most lipo-sensitive yeast strain arose due to deletion of the ″ARE2 Required for Viability″(ARV1) gene, encoding an evolutionarily conserved, potential lipid transporter that localizes to the Endoplasmic Reticulum membrane. Down-regulation of mammalian ARV1 in MIN6 pancreatic β-cells or HEK293 cells, resulted in decreased neutral lipid synthesis, increased fatty acid sensitivity and lipoapoptosis. Conversely, elevated expression of human ARV1 in HEK293 cells or mouse liver significantly increased triglyceride mass and lipid droplet number. The ARV1-induced hepatic triglyceride accumulation was accompanied by upregulation of DGAT1, a triglyceride synthesis gene, and the fatty acid transporter, CD36. Furthermore, ARV1 was identified as a target of the nuclear receptor protein PPARα, a key regulator of lipid homeostasis whose transcriptional targets include DGAT1 and CD36. These results implicate ARV1 as a protective factor in lipotoxic diseases due to modulation of fatty acid metabolism. In conclusion, a lipotoxicity-based genetic screen in a model microorganism has identified 72 human genes that may play key roles in neutral lipid metabolism and disease.
    Journal of Biological Chemistry 11/2013; 289(7). DOI:10.1074/jbc.M113.515197 · 4.60 Impact Factor

Full-text (3 Sources)

Download
43 Downloads
Available from
Jun 1, 2014